Skip to main content
Acta Ortopedica Brasileira logoLink to Acta Ortopedica Brasileira
. 2018;26(5):342–345. doi: 10.1590/1413-785220182605173445

FACTORS RELATED TO AMPUTATION LEVEL AND WOUND HEALING IN DIABETIC PATIENTS

FATORES RELACIONADOS AO NÍVEL DE AMPUTAÇÃO E À CICATRIZAÇÃO DE FERIDAS EM PACIENTE DIABÉTICOS

Daniel Baumfeld 1, Tiago Baumfeld 1, Benjamim Macedo 2, Roberto Zambelli 3, Fernando Lopes 3, Caio Nery 4
PMCID: PMC6220668  PMID: 30464719

ABSTRACT

Objective

There are no specific criteria that define the level of amputation in diabetic patients. The objective of this study was to assess the influence of clinical and laboratory parameters in determining the level of amputation and the wound healing time.

Methods

One hundred and thirty-nine diabetic patients were retrospectively assessed. They underwent surgical procedures due to infection and/or ischemic necrosis. Type of surgery, antibiotic use, laboratory parameters and length of hospital stay were evaluated in this study.

Results

The most common amputation level was transmetatarsal, occurring in 26 patients (28.9%). The wound healing time increased with statistical significance in individuals undergoing debridement, who did not receive preoperative antibiotics and did not undergo vascular intervention. Higher levels of amputation were statistically related to limb ischemia, previous amputation and non-use of preoperative antibiotics.

Conclusion

Patients with minor amputations undergo stump revision surgery more often, but the act of always targeting the most distal stump possible decreases energy expenditure while walking, allowing patients to achieve better quality of life. Risk factors for major amputations were ischemia and previous amputations. A protective factor was preoperative antibiotic therapy. Level of Evidence III, Retrospective Study.

Keywords: Diabetic foot, Amputation, Antibiotics, Wound healing, Risk factors, Protective factors

INTRODUCTION

Diabetes Mellitus is an extremely debilitating chronic disease that has taken an epidemic pattern in recent decades, becoming a real public health problem. In 2012, the diabetic population in the US was estimated at 29.1 millions of Americans, with 1.4 million diagnosis per year, which generated a 245 billion dollars cost in that same year. 1 Peripheral neuropathy is a late complication observed especially in the lower limbs and is the main cause of ulcerations on feet. 2 Secondary infection of neuropathic ulcers is the main cause of hospitalization and amputation of the lower limbs in the diabetic patient. 2 , 3 In addition, 2/3 of diabetic patients who underwent lower limb amputation died in 5 years due to bed immobilization, inadequate psychologically counseling and uncontrolled food intake. 4 According to the Brazilian Diabetes Society, every minute in the world, an amputation is performed due to diabetes. In Brazil, the real incidence of diabetes is still unknown. It is estimated that there is something around 8 million diabetics and at least another 3 million that do not have their disease diagnosed. 5 There is no statistical data that provides any criteria for indicating the correct level of amputation; however, it is known that advanced kidney disease and absence of distal pulse are factors that negatively influence the healing prognosis of diabetic amputated patients. 6

The objective of this study was to trace the epidemiological profile of persons with diabetes treated at two tertiary orthopedic hospitals and evaluate the influence of clinical and laboratory parameters in the final amputation level of the lower limbs and in the wounds' healing time.

MATERIALS AND METHODS

Between April 2007 and December 2012, 139 patients were hospitalized due to complications of diabetic foot in two tertiary orthopedic hospitals. All of them were submitted to a debridement or an amputation due to infection and/or ischemic necrosis in that affected limb. Epidemiological data from the 139 patients was retrospectively collected from medical records, consisting in: age, gender, diagnosis, type of surgical procedure, amputation level, wound healing time, culture results, antibiotic usage, need of vascular procedures and hospital length stay. The laboratory tests collected were: White Blood Cell Count (WBC), Erythrocyte Sedimentation Rate (ESR), C-Reactive Protein (CRP), Serum Albumin (SA), Creatinine and Urea. All Patients signed an informed consent. This study was aprooved by our institution ethics committee with the number 078/2015.

Mann-Whitney and Fisher tests were used, according to each analysis, to correlate the studied variables. We adopted the significance level of 5% (p<0.05) for the application of statistical tests. We used the SPSS software (Statistical Package for Social Science), in its 17.0 version, for analysis of results.

RESULTS

Descriptive Analysis

From the 139 patients studied, 106 (76.3%) were male and 33 (23.7%) were female. The average age was 64 years, ranging from 23 to 100 years. The average hospital stay was 23 days, with a minimum stay of 1 day and up to 150 days.

The most prevalent diagnoses were: ischemia, occurring in 63 cases (33.3%); osteomyelitis in 62 patients (32.8%); and infected ischemia in 34 cases (18%). We had 187 diagnoses for the 139 patients, with an average of 1.4 diagnoses per patient.

Regarding the surgeries, we had an average of 1.2 surgeries per patient, with 162 procedures. The most prevalent procedure was amputation, performed 90 times (54.9%), followed by debridement, performed 70 times (42.7%).

The most frequent amputation level were the transmetatarsal, performed in 28 patients (31.1%) and the amputation of one toe, performed in 25 patients (27.7%) (Table 1).

Table 1. Level of Amputation.

Level of Amputation Frequency %
Chopart joint 2 2.2
Metatarsophalangeal 4 4.5
Ray 6 6.6
Transfemoral 6 6.6
Transtibial 19 21.1
Toe 25 27.7
Transmetatarsal 28 31.1
Total 90 100.0

Regardless of the number of surgeries that each patient was submitted, each one of them had the final wound healing time evaluated. The time between the first surgery and the complete closure of the wound had an average of 35 days, with a minimum of 14 days and up to 730 days, in 138 patients that had this information recorded. Twenty-six patients (18.7%) did not have the final wound closure time recorded and, in three of them, this information was not recorded because the patients died.

With respect to the use of antibiotics (ATB), 89 (64.0%) patients used it before admission, 55 (40.0%) in the postoperative period and 39 (28.1%) did not use ATB. In 11 medical records this information was not found. About the ATB used before the admission, most part of the patients used Amoxicillin-Clavulanate (24.7%), followed by Ampicillin-Sulbactam (23.6%) and the combination of Ciprofloxacin and Clindamycin (18.0%). In relation to the ATBs used postoperatively, after adjustment by the culture results, most part of the patients used Amoxicillin-Clavulanate (20.0%), followed by Ampicillin-Sulbactam (11.3%) and the combination of Ciprofloxacin and Clindamycin (8.7%).

Most part of the collected cultures were positive (74.1 %), while 18.0 % had no microorganisms growth. In 7.9 % of the patients this result was not informed. The average number of bacteria found per patient was two. The greater number of bacteria found was three. The most prevalent microorganisms were: Staphylococcus aureus, occurring in 24 cultures (15.6%), Pseudomonas aeruginosa, occurring in 18 cultures (11.7 %) and Enteroccus faecalis occurring in 15 cultures (9.7%) (Table 2). The most common association between bacterias was Staphylococcus aureus + Enteroccus faecalis (7 cultures) and Pseudomonas aeruginosa + Enterobacter cloacae (4 cultures). Five cultures were positive for multidrug-resistant Staphylococcus aureus (MRSA). Four of these patients with MRSA had used antibiotics (Amoxicillin-Clavulanate) before admission.

Table 2. Most common bacterias found in positive culture results.

Bateria N %
Staphylococcus aureus 24 15,6
Pseudomonas aeruginosa 18 11,7
Enterococcus faecalis 15 9,7
Proteus mirabilis 12 7,8
Escherichia coli 12 7,8
Enterobacter cloacae 10 6,5
Klebsiella Pneumoniae 9 5,8
Serratia marcens 7 4,5

Of the 139 patients evaluated, 49 (35.3%) underwent some attempt of surgical revascularization of the lower limb. Three patients did not have any records about vascular approach.

Comparative Analysis

The statistical analysis showed that the wound healing time was impacted by several factors (Table 3). The wound healing time was longer in those patients in whom preservation of the limb was attempted through serial debridement (p=0.005) or through vascular approach (p=0.003). The wound healing time decreased in those patients in whom the amputation was the first choice of treatment (p=0.001) and in those patients that used ATB before admission (p=0.000).

Table 3. Evaluated factors Vs. Time between the first surgery and the final wound closure time.

Factors influencing in the wound closure time Category N Average time (days) p value
Amputation Yes 76 47.1 0.001*
No 30 69.8
Debridment Yes 53 62.4 0.005*
No 54 45.8
Antibiotic (before adimission) Yes 69 42.7 0.000*
No 29 65.8
Vascular approach Yes 30 67.7 0.003*
No 76 47.9
Saved limb Yes 83 49.9 0.038*
No 22 64.9
*

P<0,05

Laboratory parameters were also studied in relation to the wound healing time (Table 4). The only statistically related factor were preoperative WBC (p = 0.032 and r = 0.209), that were bigger in those patients with longer wound healing time.

Table 4. Laboratory parameters correlation with wound healing time.

Pre operative exam Average Correlation coefficient p value
WBC (/ml) 5932 0.209 0.032*
SA (g/dL) 2.82 -0.077 0.456
Creatinine (mg/dL) 1,85 -0.017 0.862
Urea (mg/dL) 56 -0.056 0.576
CRP (mg/dL) 122 -0.043 0.665
ESR (mm/h) 47 -0.214 0.073
*

p<0,05.

Regarding the level of amputation, it was observed that individuals who had higher level of amputation (above the ankle level) were those with associated ischemia diagnosis (p = 0.002) and who had already undergone previous amputation (p = 0.010). The individuals who had lower levels of amputation (at the foot level) were those who used ATB preoperatively (p = 0.004). Patients who underwent minor amputations had more surgical procedures than those who underwent major amputation (p = 0.002), an expected relationship, as a distal limb preservation require more wound care. There was no significant correlation between the length of hospital stay and the results of cultures (p = 0.311). In addition, there was no statistical relationship between length of hospital stay and wound healing time (p = 0.621).

DISCUSSION

Infection, associated to ulceration and neuropathy is the main cause of lower limb amputation in persons with diabetes. 2 The relevance of wounds in the lower limb of those patients is extremely important, since it can reach around 10-65/1000 patients per year, which is more than the rate of amputation, which can vary between 3.7 to 12.5/1000 patients per year. 7 In our study population, infection was present in 50.8 % of patients (osteomyelitis or infected ischemia), corroborating with the worldwide literature. It is also known that the risk of amputation in a diabetic patient is 10 to 15 times higher than in general population. 8 The mortality of patients with late complications of diabetes is extremely high and is related to age, poor glycemic control and depression. 9 Major amputations (ankle, transtibial or transfemoral) are associated with a lower survival rate than minor amputations (midfoot, rays or toes) 10 which lead orthopedic surgeons to continually look for factors that may influence on the level of amputation to be selected.

On this study, minor amputations (80,6%) were more frequent than major amputations (18.4%). Despite the findings of Dillinghan et al, 9 that patients with minor amputation are more often submitted to amputation revisions for a more proximal level, increasing the cost to the health system, we believe that the search for the most distal stump possible, regardless the healing time and the number of interventions necessary for such, decreases energy expenditure during walking, increasing the quality of life of post-amputated patients. It is believed that treating the patient in an early stage of neuropathy, allied to a multidisciplinary approach, positively influences limb preservation. 11 All patients with ischemic injury, infected or not, in the lower limbs should receive clinical assessment by a general practitioner or endocrinologist, a vascular surgeon, an orthopedic surgeon, an infectious disease specialist, a plastic surgeon and a curative commissioner nurse, optimizing care and establishing priorities for the medical team.

Patients undergoing major amputations were those with more severe injuries indicated by a greater statistical frequency of associated ischemia and previous amputations. 12 , 13 According to Pollard et al., 6 patients with palpable dorsalis pedis pulse have better healing and do not require further amputation in most cases. Santos et al. 14 found that patients with chronic arterial insufficiency without possibility of revascularization have a higher risk of a major amputation.

It should be noted that the use of ATB before surgery was a protective factor for major amputation, which may indicate that the use of empirical ATB can prevent the evolution of a simple to a severe injury, allowing smaller ablations.

Also related to ATB ‘s, it is noteworthy that the antibiotics used empirically followed the same frequency of use of the antibiotics oriented by the culture, being the use of Amoxicillin-Clavulanate the most frequent, followed by Ampicillin-Sulbactam and the combination of Ciprofloxacin and Clindamycin. Furthermore, it was observed that the use of preoperative ATB was a factor that decreased the patients wound closing time.

The type of intervention also affected the wounds closing time. Therefore, it should be attempted that, if the surgeon chooses to preserve the limb with vascular interventions and debridement, the wound closure time will be longer compared to a patient in which it is opted for ablative therapy.

Several laboratorial parameters influence the frequency of amputations. The nutritional status and patient immunocompetence are important factors when planning to perform an amputation in an individual with diabetes. It is known that SA levels below 3.0 g / dl and total lymphocyte count less than 1,500 / mm3 are considered poor prognostic factors leading to early progression of the amputation level. 4 Furthermore, the presence of advanced kidney disease is an independent risk factor for major amputations. 6 , 10 In this study, the only laboratorial parameter that presented statistical correlation was the number of preoperative leukocytes. The increase in leukocytes number was a predictor of a longer wound healing time, which is clearly explained by the fact that infected wounds present major challenges to the healing process.

CONCLUSION

This study shows that major amputations have as risk factors ischemia and previous amputations and as a protective factor the use ATB preoperatively. The wound healing time declines with the use of preoperative ATB and increases if the patient underwent vascular intervention or has higher Leukocyte levels preoperatively and / or had their member preserved, demanding multiple debridement.

ACKNOWLEDGEMENTS

We are grateful for our hospital medical records team, who made this retrospective analysis possible.

Footnotes

Work conducted at the Hospital Mater Dei and Hospital Felício Rocho.

REFERENCES

  • 1.American Diabetes Association Diabetes Statistics. 2012. [Accessed 21.08.2016]. Disponível em http://www.diabetes.org/diabetes-statistics.jsp/
  • 2.Pecoraro R, Reiber G, Burgess E. Pathways to diabetic limb amputations. Basis for prevention. Diabetes Care. 1990;13(5):513–521. doi: 10.2337/diacare.13.5.513. [DOI] [PubMed] [Google Scholar]
  • 3.Pinzur MS, Slovenkai MP, Trepman E. Diabetes Committee of American Orthopaedic Foot and Ankle Society. Guidelines for diabetic foot care: recommendations endorsed by the Diabetes Committee of American Orthopaedic Foot and Ankle Society. Foot Ankle Int. 2005;26(1):113–119. doi: 10.1177/107110070502600112. [DOI] [PubMed] [Google Scholar]
  • 4.Philbin TM, Leyes M, Sferra JJ, Donley BG. Orthotic and prosthetic devices in partial foot amputations. Foot Ankle Clin. 2001;6(2):215–228. doi: 10.1016/s1083-7515(03)00090-1. [DOI] [PubMed] [Google Scholar]
  • 5.Lavery LA, Wunderlich RP, Tredwell JL. Disease management for the diabetic foot: Effectiveness of diabetic foot prevention program to reduce amputations and hospitalizations. Diabetes Res Clin Pract. 2005;70(1):31–37. doi: 10.1016/j.diabres.2005.02.010. [DOI] [PubMed] [Google Scholar]
  • 6.Pollard J, Hamilton GA, Rush SM, Ford LA. Mortality and morbidity after transmetatarsal amputation: retrospective review of 101 cases. J Foot Ankle Surg. 2006;45(2):91–97. doi: 10.1053/j.jfas.2005.12.011. [DOI] [PubMed] [Google Scholar]
  • 7.Reiber GE, Smith DG, Wallace C, Sullivan K, Hayes S, Vath C, et al. Effect of therapeutic footwear on foot reulceration in patients with diabetes: A randomized controlled trial. JAMA. 2002;287(19):2552–2558. doi: 10.1001/jama.287.19.2552. [DOI] [PubMed] [Google Scholar]
  • 8.Trautner C, Haastert B, Giani G, Bergert M. Amputations and diabetes: a case-control study. Diabetic Med. 2002;19(1):35–40. doi: 10.1046/j.1464-5491.2002.00612.x. [DOI] [PubMed] [Google Scholar]
  • 9.Dillingham TR, Pezzin LE, Shore AD. Reamputation mortality heath care costs among persons with dysvascular lower limb amputations. Arch Phys Med Rehabil. 2005;86(3):480–486. doi: 10.1016/j.apmr.2004.06.072. [DOI] [PubMed] [Google Scholar]
  • 10.Larsson J, Agardh CD, Apelqvist J, Stenstrom A. Long-term prognosis after healed amputation in patients with diabetes. Clin Orthop Relat Res. 1998;350:149–158. [PubMed] [Google Scholar]
  • 11.Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. N Engl J Med. 1994;331:854–860. doi: 10.1056/NEJM199409293311307. [DOI] [PubMed] [Google Scholar]
  • 12.Davis WA, Norman PE, Bruce DG, Davis TM. Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: the Fremantle Diabetes Study. Diabetologia. 2006;49(11):2634–2641. doi: 10.1007/s00125-006-0431-0. [DOI] [PubMed] [Google Scholar]
  • 13.Adler AI, Boyko EJ, Ahroni JH, Smith DG. Lower-extremity amputation in diabetes. Diabetes Care. 1999;22(7):1029–1035. doi: 10.2337/diacare.22.7.1029. [DOI] [PubMed] [Google Scholar]
  • 14.Santos VP, Silveira DR, Caffaro RA. Risk factors for primary major amputation in diabetic patients. Sao Paulo Med J. 2006;124(2):66–70. doi: 10.1590/S1516-31802006000200004. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Acta Ortopedica Brasileira are provided here courtesy of Department of Orthopedics and Traumatology, Faculdade de Medicina da Universidade de São Paulo

RESOURCES